Production (Stage)
E
Drugs Made In America Acquisition Corp. DMAA
$10.18 -$0.01-0.10% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

03/31/2025
Total Cash And Short-Term Investments -35.71%
Total Receivables --
Inventory --
Prepaid Expenses 1,847.22%
Finance Division Loans and Leases Current --
Total Finance Division Other Current Assets --
Other Current Assets --
Total Current Assets 1,320.00%

Total Current Assets 1,320.00%
Net Property, Plant & Equipment --
Long-term Investments --
Goodwill --
Total Other Intangibles --
Finance Div Loans & Leases LT --
Total Finance Div Other LT Assets --
Total Other Assets 42,541.17%
Total Assets 42,166.98%

Total Accounts Payable --
Total Accrued Expenses 71.41%
Short-term Debt -90.80%
Current Portion of Long-Term Debt/Capital Leases --
Finance Division Debt Current --
Total Finance Division Other Current Liabilities 174.51%
Total Other Current Liabilities 174.51%
Total Current Liabilities -56.34%

Total Current Liabilities -56.34%
Long-Term Debt --
Short-term Debt -90.80%
Capital Leases --
Finance Division Debt Non Current --
Total Finance Division Other Non Current Liabilities --
Total Other Liabilities --
Total Liabilities 30,059.96%

Common Stock & APIC -96.86%
Retained Earnings -2,160.54%
Treasury Stock & Other --
Total Common Equity -2,831.54%

Preferred Stock Redeemable --
Preferred Stock Non Redeemable --
Preferred Stock Convertible --
Preferred Stock, Others --
Total Preferred Equity --

Total Common Equity -2,831.54%
Total Preferred Equity --
Total Minority Interest --
Total Equity -2,831.54%